Fiji vs Slovakia: HIV/AIDS deaths averted by antiretroviral therapy
Fiji
82.71 deaths
in 2024
Slovakia
81.33 deaths
in 2024
Fiji rank
128th
Slovakia rank
129th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Fiji
- Slovakia
How they compare
Fiji currently reports 82.71 deaths against 81.33 deaths in Slovakia, a difference of 1.38 deaths.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Slovakia ahead.
Fiji ranks 128th and Slovakia ranks 129th of 157 countries.
Slovakia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Fiji | Slovakia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0.3745 deaths | 0.3745 deaths | Slovakia |
| 2000s | 0.4499 deaths | 8.43 deaths | 7.98 deaths | Slovakia |
| 2010s | 13.52 deaths | 26.27 deaths | 12.76 deaths | Slovakia |
| 2020s | 53.81 deaths | 60.95 deaths | 7.14 deaths | Slovakia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Fiji or Slovakia?
- Fiji, at 82.71 deaths against 81.33 deaths in Slovakia as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Fiji and Slovakia?
- 1.38 deaths, with Fiji ahead.
- How many years of comparable data are there for Fiji and Slovakia?
- 35 years are reported by both, from 1990 to 2024.
- How do Fiji and Slovakia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Fiji ranks 128th and Slovakia ranks 129th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.